FD 892
Latest Information Update: 22 Mar 2007
At a glance
- Originator Taisho Pharmaceutical
- Class Cytostatic antibiotics; Macrolides
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 09 Jan 1995 Preclinical development for Cancer in Japan (unspecified route)